Logo

Oncormed Granted US Patent for BRCA1 Gene Coding Sequence

Dec 22, 1998
Premium

GAITHERSBURG, Md.--Oncormed here has received a US patent on a full-length coding sequence of the BRCA1 gene that encodes the entire BRCA1 protein. The company's rights in the patented sequence include therapeutics and diagnostic products and services. The company also recently received a worldwide exclusive license to the BRCA2 gene for diagnostic purposes.

"Our objective with respect to this intellectual property is to license BRCA1 for therapeutic use and to broadly license both BRCA1 and BRCA2 for diagnostic development and commercialization," noted Timothy Triche, Oncormed's chairman and CEO. Oncormed develops and provides gene-based diagnostic and information services.

Filed under

Informatics
Breaking News
The Scan

Genome Sequences Reveal Range Mutations in Induced Pluripotent Stem Cells

Researchers in Nature Genetics detect somatic mutation variation across iPSCs generated from blood or skin fibroblast cell sources, along with selection for BCOR gene mutations.

Researchers Reprogram Plant Roots With Synthetic Genetic Circuit Strategy

Root gene expression was altered with the help of genetic circuits built around a series of synthetic transcriptional regulators in the Nicotiana benthamiana plant in a Science paper.

Infectious Disease Tracking Study Compares Genome Sequencing Approaches

Researchers in BMC Genomics see advantages for capture-based Illumina sequencing and amplicon-based sequencing on the Nanopore instrument, depending on the situation or samples available.

LINE-1 Linked to Premature Aging Conditions

Researchers report in Science Translational Medicine that the accumulation of LINE-1 RNA contributes to premature aging conditions and that symptoms can be improved by targeting them.